Is single incision midurethral sling effective in patients with low maximal urethral closure pressure?  by Sun, Mou-Jong et al.
lable at ScienceDirect
Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 20e25Contents lists avaiTaiwanese Journal of Obstetrics & Gynecology
journal homepage: www.t jog-onl ine.comOriginal ArticleIs single incision midurethral sling effective in patients with low
maximal urethral closure pressure?
Mou-Jong Sun a, b, c, *, Ryan Sun d, Shiuan-Hui Tseng b
a Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Changhua Christian Hospital, Changhua, Taiwan
b Center for Urinary Incontinence and Voiding Dysfunction, Changhua Christian Hospital, Changhua, Taiwan
c General Education Center, Chien Kuo Technology University, Changhua, Taiwan
d Faculty of Medicine, University of Toronto, Toronto, Canadaa r t i c l e i n f o
Article history:
Accepted 12 September 2014
Keywords:
comparison
efﬁcacy
low maximal urethral closure pressure
MiniArc
single incision sling* Corresponding author. Center for Urinary
Dysfunction, Division of Urogynecology and Rec
Department of Obstetrics and Gynecology, Changhu
Nanxiao Street, Changhua City, Changhua County 500
E-mail address: 13212@cch.org.tw (M.-J. Sun).
http://dx.doi.org/10.1016/j.tjog.2014.09.013
1028-4559/Copyright © 2016, Taiwan Association of O
(http://creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Objective: To ascertain whether low preoperational maximal urethral closure pressure (MUCP) affects
the outcomes of single incision sling (SIS) procedures and changes MUCP values postsurgery.
Material and methods: There were 112 (MUCP  40 cmH2O, n ¼ 88; MUCP < 40 cmH2O, n ¼ 24)
consecutive women with urodynamic stress incontinence who had undergone SIS (MiniArc) procedures
included in this study. The threshold of 40 cmH2O was used since it has been shown to be a signiﬁcant
risk factor for failed incontinence surgery. Clinical outcomes were assessed by the cough stress test, the
1-hour pad test, the Incontinence Impact Questionnaire-Short Form, the Urogenital Distress Inventory
six-item questionnaire, the Sexual Questionnaire-SF, and postoperative changes in the urodynamic pa-
rameters. A comparison of the 1-year follow-up data is presented.
Results: Three months postsurgery, a signiﬁcant decrease was observed in the 1-hour pad test, from
20.6 g preoperatively to 0.73 g postoperatively (p < 0.001). The objective cure rate was 82.1% without any
signiﬁcant differences between the two groups (p ¼ 0.202). At 3 months and 1 year after surgery,
signiﬁcantly decreasing Urogenital Distress Inventory six-item questionnaire and Incontinence Impact
Questionnaire-Short Form, and increasing Sexual Questionnaire-SF scores were observed in both groups,
without any signiﬁcant differences between the two groups. No statistically signiﬁcant difference in the
subjective cured rate was noted between the two groups at the 3-month and 18.4 month follow-ups. The
postoperative MUCP was signiﬁcantly decreased in the MUCP  40 group (p < 0.05) while signiﬁcantly
increased in the MUCP < 40 group (p ¼ 0.006).
Conclusions: These results suggest that SIS is a safe and highly effective treatment for urodynamic stress
incontinence even in women with low MUCP at a mean follow-up of 18.4 months. Evaluation of the
outcomes with more subjects after a longer follow-up period is necessary.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
The surgical treatment of urodynamic stress incontinence (USI)
due to urethral hypermobility has changed radically since the
introduction of the tension-fee vaginal tape (TVT) procedure, ﬁrst
described by Ulmsten and Petros [1] in 1995.With a highIncontinence and Voiding
onstructive Pelvic Surgery,
a Christian Hospital, No.135,
, Taiwan.
bstetrics & Gynecology. Publishedsatisfaction rate without serious tape-induced long-term adverse
effects, TVToperation has become the gold standard of incontinence
surgery [2]. The longest follow-up to date of TVT performance
showed that over 90% of the treated women were objectively
continent and 87% had signiﬁcantly improved or were subjectively
cured, which suggests that the TVT operation for the treatment of
female USI is a durable procedure, with an efﬁcacy lasting even
beyond 17 years [2]. Further developments in the obturator route
have resulted in the use of second-generation midurethra tape
placement to address the postoperative bowel, bladder, and major
blood vessel injuries observed in many case reports [3,4]. The
MiniArc single-incision sling (SIS) is the third generation ofby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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incision vaginal approach and self-ﬁxating tape with anchoring
tips that causes tension in the internal obturator muscles. The
objective cure rate for MiniArc is described in the literature as being
90.6% after 1 year, comparable with the results for conventional
midurethral tape [5]. The 2-year overall objective results were 81
(85.3%) patients dry [6]. In addition, the SIS and the transobturator
sling are equally effective and safe for the treatment of stress in-
continence, as evaluated during the 1-year follow-up [7].
Patients with intrinsic sphincter deﬁciency (ISD) are often more
difﬁcult to cure through surgery. Prior studies showed that MUCP is
predictive of USI outcomes following continence surgery. Women
with low urethral closure pressure (LUCP) have been associated
with an increased failure of surgical procedures to correct USI
[8e11].
Although there is a rapidly expanding literature about SIS, to
date, very few studies have focused on the possibility of using an SIS
procedure to manage women with LUCP or how the SIS operation
affects the MUCP value [7]. Prior studies showed that, in patients
with an MUCP of  42 cmH2O, the tension-free obturator tape
(TOT) was nearly six times more likely to fail than TVT at 3 months
postsurgery [10], and that the risk factors affecting cure after
midurethral tape procedures were preoperative detrusor over-
activity for TVT and TOT and MUCP < 40 cmH2O for the TOT pro-
cedure [11]. It would be pertinent to establish whether patients
with low MUCP (< 40 cmH2O) would suffer a worse outcome
following an SIS procedure.
The aim of the present study was to evaluate the efﬁcacy of the
SIS procedure (MiniArc) in women suffering from USI with the
coexistence of LUCP and how this might change the MUCP values
postsurgery.
Materials and methods
We included consecutive patients with clinically and urody-
namically proven USI between January 2010 and December 2012.
The SISs investigated in the study were available from Changhua
Christian Hospital, a tertiary medical center situated in central
Taiwan.
All patients included had been indicated for the surgical treat-
ment of their USI with or without a concomitant reconstructive
procedure. Patients who had a neurogenic bladder, detrusor over-
activity, or loss of follow-up, were excluded. All of the surgical
procedures were performed by one senior urogynecologist with
adequate experience of sling surgery (having performed > 20
MiniArc slings) to avoid intersurgeon variation. All of the pro-
cedures were performed in the modiﬁed dorsal lithotomy position.
All patients were given preoperative broad-spectrum intravenous
antibiotics and were operated on under intravenous general anes-
thesia. The MiniArc (American Medical Systems, Minnetonka, MN,
USA).was inserted according to the original description [12] to
ensure a pillow-effect tension. Cystoscopy was performed on each
patient following sling insertion to verify the absence of bladder
injury. A urinary catheter was inserted before the sling implanta-
tion and removed on the day following surgery. The postvoid re-
sidual urine was then measured before the patient was discharged
from hospital. In cases of voiding difﬁculty (i.e., > 100 mL residual
urine), hospitalization was prolonged until a postvoid residual of
< 100 mL was obtained.
Patients with MUCP of < 20 cmH2O were diagnosed with
intrinsic urethral sphincter deﬁciency or USI Type III, according to
International Continence Society (ICS). However, very few patients
had MUCP of < 20 cmH2O. Since women with LUCP have been
associated with the increased failure of incontinence surgery [8,9],
and a low MUCP of < 42 cmH2O [10] and < 40 cmH2O [11] havebeen found to be signiﬁcant risk factors affecting the treatment
outcome, we categorized patients using a cut-off MUCP value of
40 cmH2O to deﬁne low urethral closure for the purpose of this
study. Although this grouping does not follow the standard out-
lined by the ICS, the observations made in comparing the two pa-
tient groups remain valuable.
Preoperative evaluations included a detailed history, physical
examination, cough stress test, and 1-hour pad test; preoperative
urodynamic studies included uroﬂowmetry, static and dynamic
urethral pressure proﬁles, urethrocystometry, and postvoid resid-
ual (PVR), measured using a bladder scan. All urodynamic tracings
were interpreted by the physician performing the study. Maximal
urethral closure pressures were performed at cystometric capacity
with an electronic puller arm. Before intervention, and at the 3-
month postoperative follow-up, the patients completed two vali-
dated quality-of-life questionnaires: the Urogenital Distress In-
ventory six-item questionnaire (UDI-6) and the Incontinence
Impact seven-item short-form Questionnaire (IIQ-7) [13]. The IIQ-7
and UDI-6 were scored according to the established protocols. The
mean values for all completed IIQ and UDI items (range 0e3) were
calculated. The Sexual Questionnaire-short form (PIS-Q SF [14]),
limited to ﬁve questions, was only completed by patients with
sexual activity.
Postoperative follow-up visits were scheduled at 1 week, and
3 months, 6 months, 12 months, and 24 months. Charts produced
from the study were reviewed both subjectively and objectively,
including the need for urgent medication, urinary retention, and
other perioperative complications. Uroﬂowmetry, static and dy-
namic urethral pressure proﬁles, urethrocystometry and PVR, a 1-
hour pad test, and cough provocation tests were performed post-
operatively at 3 months. Patients were deﬁned as having been
objectively cured when they had a negative cough stress test. After
3 months, the subjective outcomes were collected via telephone
interviews by an experienced nurse using the UDI-6, IIQ-7, and PIS-
Q questionnaires. Patients were deﬁned as being subjectively cured
when they responded negatively to the third question on the UDI-6.
Postoperative voiding difﬁculty was deﬁned as residual urine of >
100 mL, any experience of hesitancy in voiding, weak stream or a
discontinuous ﬂow, or an amount of postvoid residual more than
two-thirds of that from self-voiding.
Statistical analysis was performed using the Student t test for
parametric and nonparametric continuous variables, and the Wil-
coxon signed rank test or Fisher exact test for the categorical var-
iables. A p value of < 0.05 was considered statistically signiﬁcant.
In this study, the methods, deﬁnitions, and units used conform
to the standards jointly recommended by the International Uro-
gynecological Association and the ICS, except where speciﬁcally
noted [15]. The complications are described according to the In-
ternational Urogynecological Association/ICS terminology and
classiﬁcation [16].Results
There were 118 consecutive patients with urodynamic stress
incontinence included in this study; six (4 with MUCP 40 cmH2O,
2 with MUCP < 40 cmH2O) were excluded because of a lack of
follow-up data. The basic background of the study participants is
shown in Table 1. Eighty-eight patients had MUCP  40 cmH2O and
24 had MUCP < 40 cmH2O. The mean follow-up period was
18.4 months. The two groups are comparable with regard to body
mass index, history of previous hysterectomy and incontinence
operation, 1-hour pad test, IIQ-7, UDI-6, PIS-Q, and follow-up
period (Table 1). Women with MUCP < 40 cmH2O were signiﬁ-
cantly older and had higher parity (p < 0.05).
Table 1
Patient demographics and main characteristics.
MUCP  40 cmH2O (n ¼ 88) MUCP < 40 cmH2O (n ¼ 24) Total (n ¼ 112) p
Age (y) 51.8 ± 8.2 59.0 ± 9.5 53.3 ± 9.0 <0.001
Parity 2.8 ± 1.1 3.4 ± 1.0 2.9 ± 1.1 0.013
Body mass index (kg/m2) 24.6 ± 3.1 25.6 ± 3.3 24.8 ± 3.2 0.299
Prior hysterectomy 16 (18.2) 6 (25.0) 22 (19.6) 562
Prior incontinence procedure 4 (4.5) 3 (12.5) 7 (6.3) 0.167
1-h pad test (g) 20.6 ± 17.9 20.5 ± 16.7 20.6 ± 17.5 0.779
UDI-6 42.6 ± 18.3 47.2 ± 21.3 43.6 ± 19.1 0.361
IIQ-7 56.5 ± 25.7 64.43 ± 17.19 58.20 ± 24.26 0.083
MUCP (cmH2O) 75.2 ± 22.7 31.2 ± 6.5 65.7 ± 27.2 <0.001
Concomitant hysterectomy 12 (13.6) 1 (4.1) 13 (11.1) >0.999
Concomitant vaginal anterior repair 8 (9.1) 3 (12.5) 11 (9.8) >0.999
Single incision sling alone 66 (75.0) 20 (83.3) 86 (76.8) >0.999
Mean period of follow-up (mo) 18.2 ± 7.1 19.5 ± 7.2 18.4 ± 7.8 0.365
Data are presented as n (%) or mean ± standard deviation; p-value by the ManneWhitney U test and Chi-square test.
IIQ-7 ¼ Impact Questionnaire; MUCP ¼ maximal urethral closure pressure; UDI6 ¼ Urogenital Distress Inventory.
Table 2
Comparison of operative and postoperative complications.
MUCP  40 cmH2O (n ¼ 88) MUCP < 40 cmH2O (n ¼ 24)
Intra and postoperative
immediate
Postoperative
3 months
Postoperative
1 year
Intra and postoperative
immediate
Postoperative
3 months
Postoperative
1 year
Urinary tract infection 6.80% 0 0 4.20% 0 0
Pain (VAS > 3 day 1 or day 2) 0 0 0 0 0 0
Urinary retention 0 0 0 0 0 0
De novo urgency, n (%) 0 3 (3.4) 1 (1.1) 0 1 (4.7) 1 (4.7)
Bladder perforation 0 0
Urethra injury 0
De novo dyspareunia (n ¼ 51) 0 0 0 0
Tape erosion 0 0
No signiﬁcant differences between the complications among the two groups (p > 0.05).
MUCP ¼ maximal urethral closure pressure; VAS ¼ visual analogue scale.
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occurrence of any major intraoperative complication (bladder and
urethra injury, bleeding > 500 mL, nerve lesions), immediate
postoperative urinary retention (residual urine volume >100 mL
over 24 hours), prolonged urinary retention requiring sling release,
or tape exposure, de novo dyspareunia at 18.4 months postsurgery.
Only three patients in the MUCP  40 cmH2O group and one in the
MUCP < 40 cmH2O group had slight de novo urgency with an UDI-6
score of 1 at 13 months postsurgery.
Table 3 show the comparison of the objective and subjective
outcomes preoperation, at 3 months, and at 18.4 months post-
operation. The postoperative objective outcomes were evaluated at
3 months, showing a signiﬁcant decrease in the 1-hour pad testTable 3
Comparison of the objective and subjective outcomes preoperation (preop) at 3 months
MUCP  40 cmH2O
Preop n ¼ 88 3 mo postop
n ¼ 88
18.4 mo postop
n ¼ 88
1- hour pad test (g) 20.6 ± 17.6 0.7 ± 2.3 (n ¼ 60) d
Objective cure rate 91.8% (n ¼ 60) d
UDI-6 Q3 answer is no 0% 88.50% 81.60%
IIQ-7 (mean ± SD) 56.5 ± 25.7 2.6 ± 6.9 3.8 ± 8.6
UDI-6 (mean ± SD) 42.6 ± 18.3 5.2 ± 8.5 5.9 ± 4.1
PISQ (mean ± SD) 35.6 ± 5.8 39.1 ± 3.3 39.1 ± 2.0
(n ¼ 63) (n ¼ 22) (n ¼ 46)
No signiﬁcant differences between the objective and subjective outcomes between the tw
postoperatively.
IIQ-7 ¼ Incontinence Impact Questionnaire; MUCP ¼ maximal urethral closure pressure
short form, limited to ﬁve questions, only for patients with sexual activity; Q3 ¼ UDI-6
ing, or sneezing?”; UDI- 6 Urogenital Distress Inventory.result from 20.6 g preoperatively to 0.73 g postoperatively
(p < 0.001) without any signiﬁcant difference between the
MUCP  40 cmH2O group and the MUCP < 40 cmH2O group. The
objective cure rate (patients with a negative cough test) was 82.1%
(85.0% for the MUCP  40 cmH2O group, 72.2% for the
MUCP < 40 cmH2O group, p ¼ 0.202), without any signiﬁcant dif-
ference between the two groups. Subjective outcomes were
recorded 3 months postsurgery and during the most recent post-
operative telephone interview at a mean follow-up at
18.4 ± 7.8 months. At 3 months and 18.4 months postsurgery, sig-
niﬁcant decreases in the UDI-6 and IIQ-7 and increases in the PIS-Q
scores were observed for both groups (p < 0.001), without a sig-
niﬁcant difference between the two groups (p > 0.05). Theand 18.4 months postoperation (postop).
MUCP < 40 cmH2O
p* Preop
n ¼ 24
3 mo postop
n ¼ 24
18.4 mo postop
n ¼ 24
p*
<0.001 20.5 ± 16.7 0.9 ± 2.1 (n ¼ 18) d <0.001
88.9% (n ¼ 18) d
<0.001 0% 83.30% 79.20% <0.001
<0.001 64.4 ± 17.2 5.8 ± 16.4 2.7 ± 6.6 <0.001
<0.001 47.2 ± 21.3 5.2 ± 8.2 4.3 ± 8.2 <0.001
<0.001 34.5 ± 6.1 38.0 ± 3.5 38.8 ± 2.7 0.068
(n ¼ 10) (n ¼ 3) (n ¼ 5)
o groups (p > 0.05). *Intragroup analysis of preoperatively vs. 3 months and 1 year
; Objective cure rate ¼ negative cough stress test; PISQ ¼ sexual questionnaire-SF,
Question 3: “Do you experience urine leakage related to physical activity, cough-
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the UDI-6 Question 3, “Do you experience urine leakage related to
physical activity, coughing, or sneezing?” No statistically signiﬁcant
difference was noted between the two groups at the 3-month
(88.5%, 83.3% respectively, p ¼ 0.498) and 18.4 month follow-up
(81.6%, 79.2% respectively, p ¼ 0.774).
The preoperative and postoperative urodynamic changes
(Table 4) revealed a statistically signiﬁcant decrease in the maximal
ﬂow rate and average ﬂow rate in theMUCP 40 cmH2O group, but
not in the MUCP < 40 cmH2O group. More importantly, there was a
statistically signiﬁcant decrease in the MUCP in the MUCP 
40 cmH2O group (p < 0.001) but a statistically signiﬁcant increase
in the MUCP < 40 cmH2O group (p ¼ 0.006).
Discussion
Urethral closure pressure is, by far, the parameter most char-
acteristic of stress incontinence [17]. Maximal urethral closure
pressure is the parameter that differed the most between the
groups, being 43% lower in women with stress incontinence than
similar asymptomatic women [17]. A gradual decline in the MUCP
of approximately 15% per decade can be observed [18]. Vaginal
birth is an established risk factor for urinary incontinence. The basic
background of the study participants, showing that the patients
with MUCP < 40 cmH2O were signiﬁcantly older and had higher
parity (p < 0.05), indicated that MUCP is more strongly associated
with child birth and aging than body mass index, prior hysterec-
tomy, or prior incontinence procedure.
ISD has been deﬁned by McGuire as a condition in which the
MUCP is < 20 cmH2O [8]. ISD describes a urethral sphincter
mechanism that lacks the coaptation or normal closing pressure
needed to prevent leakage on exertion. Although the concept of ISD
and its clinical relevance continue to be debated, it remains the
biggest clinical challenge associated with anti-incontinence oper-
ations [19]. The scientiﬁc evidence supporting the use of ISD as a
parameter to provide prognostic information about the success of
anti-incontinence surgery is unclear. However, it remains impor-
tant to identify patients with ISD because it has been associated
with poor outcomes for operations in women with stress inconti-
nence [8e11,20]. In the surgical treatment of ISD, the urethral
closure mechanism is considered to function poorly and pubova-
ginal slings have been the procedure of choice [21]. They have a
high cure rate, but constitute major surgery and are invasive.
MUS procedures have been found to be a safe and effective
treatment of choice in USI. Although the tension-free vaginal tape
(TVT) procedure is considered to be the gold standard, with
excellent long-term efﬁcacy [21], the success rates of tension-free
slings in women with USI with ISD range from 24e84% and show
satisfactory outcomes with rates of 73e91% [22]. However, serious
complications have been reported with this technique, including
vascular and bowel injuries [23]. To minimize these complications,
an alternative procedure called the TOT procedure was developedTable 4
Comparison of the urodynamic parameters changes preoperation (preop) and postopera
MUCP  40 cmH2O
Preop, n ¼ 88 3 mo postop, n ¼ 63 p
MAX (mL/s) 21.7 ± 8.5 18.7 ± 7.5
AVG (mL/s) 10.7 ± 4.4 8.6 ± 4.0
VVOL (mL) 309.6 ± 144.6 310.9 ± 140.3
PVR (mL) 31.1 ± 52.0 34.4 ± 42.0
MUCP (cmH2O) 75.2 ± 22.7 58.72 ± 23.5 <
p-value by Wilcoxon signed ranks test.
AVG ¼ average ﬂow rate; MAX ¼ maximal ﬂow rate; MUCP ¼ maximum urethral closurinwhich the tape is introduced through the obturator foramen. TOT
has been used for the treatment of USI patients along with TVT, and
there have been a few reports on its outcomes for USI with ISD.
Costantini et al [24] reported that the cure rate for the TOT pro-
cedure was 77.3% in women with ISD. Guerette et al [25] reported
that transobturator slings should be used with caution in women
with impaired urethral function (Valsalva leak-point
pressure < 60 cmH2O and MUCP < 40 cmH2O). Our prior study
(2011) [26] assessed the efﬁcacy and safety of Monarc (American
Medical Systems, Minnetonka, MO, USA) transobturator sub-
urethral slings in the treatment of female USI. The objective cure
rate was 80.8% (dry pad test and negative stress test), 82.4% for
MUCP < 30 cmH2O, and 80.4% for MUCP > 30 cmH2O (p > 0.999).
Schierlitz et al [27] compared the efﬁcacy of tension-free vaginal
tape (TVT) with the use of transobturator tape in the treatment of
women with USI and ISD at 3-year follow-up. The risk ratio of
repeat surgery was 15 times (p < 0.001) greater in the trans-
obturator tape group. It was concluded that the long-term cure
rates for retropubic TVT are signiﬁcantly greater than for trans-
obturator tape inwomenwith USI and ISD. These ﬁndings also have
important implications for the signiﬁcance of ISD as a poor prog-
nostic indicator for continence surgery and suggest that urethral
functions tests, such as urethral closure pressure and Valsalva leak
point pressures, are of value in determining what kind of surgery to
perform.
The MiniArc single-incision sling is the third generation of MUS
for female USI, which uses a single-incision vaginal approach and
self-ﬁxating tape with anchoring tips that causes tension in the
internal obturator muscles. The following improvements are
possible: the elimination of external incisions; the elimination of
mesh lateral to the obturator, the reduction of anesthesia use; a
further reduction in the procedure time; and allowing patients to
return to their normal activities more quickly. A 2-year follow-up of
the MiniArc system indicated that 82e93% of the patients were
continent [28]. Comparisons between the conventional MUS and
Mini Arc remain sparse. To date, few published data exist to support
the use of the MiniArc MUS in place of alternative, commercially-
available MUSs. Our prior comparative study [10] of a single-
incision sling (MiniArc) and a transobturator sling (TVT-O) found
that these are equally as effective and safe for the treatment of
stress incontinence. These results were also comparable with the
results of De Ridder et al, in which, at 1 year, 85% of the MiniArc
group and 89% of the Monarc group (p ¼ 0.60) maintained a
negative contraction stress test [29].
In this comparative study, we grouped patients using a cut-off
value of MUCP < 40 cmH2O for special occasions, which does not
follow the ICS's standard, but the mean MUCP of the two groups
showed signiﬁcant differences (75.2 cmH2O vs. 31.2 cmH2O, p <
0.001), so the observations of the grouped patients remain
valuable.
To date, reports on the SIS outcomes for USI with ISD remain
sparse. In this study, we seek to ascertain whether SIS (MiniArc) istion (postop).
MUCP < 40 cmH2O
Preop, n ¼ 24 3 mo postop, n ¼ 18 p
0.006 17.0 ± 7.1 18.8 ± 7.1 0.345
0.001 10.4 ± 6.4 9.3 ± 3.8 0.975
0.819 240.6 ± 113.7 307.0 ± 101.5 0.065
0.646 39.9 ± 79.9 29.4 ± 48.9 0.472
0.001 31.2 ± 6.8 46.44 ± 19.9 0.006
e pressure; PVR ¼ postvoid residual volume; VVOL ¼ total voiding volume.
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group had a slightly lower negative cough test rate, the results
showed no signiﬁcant differences between the objective and sub-
jective outcomes between the two groups (p > 0.05). As in our prior
study [7] and Kennelly et al's [28] results of SIS operations, the
patients who received MiniArc procedures showed a satisfactory
outcome that had signiﬁcantly decreased their 1-hour pad results,
from 20.6 g preoperatively to 0.73 g. A 82.1% negative cough stress
at 3 months postoperatively (p < 0.001), an 87.4% (at 3 months) and
81.1% (at mean 18.4 months follow-up) subjective cured rate,
signiﬁcantly decreasing UDI-6 and IIQ-7, and increasing PIS-Q
scores at 3 months and > 1 year postoperatively were observed
with very few perioperative complications being reported.
Although these were not long-term outcomes, these satisfactory
results suggest that SIS is a highly-effective treatment for USI even
in women with low MUCP at a mean follow-up of over 1 year.
Adverse events were relatively uncommon in both of our
groups, with little blood loss and no bladder or urethra injury,
hematoma, or vaginal erosions. There were no episodes of urinary
retention in either group immediately postsurgery or in the over 1-
year follow-ups. High de novo urgency (over 30%) was reported
[29], but in this study, only a very few such cases (<5%) occurred in
both groups. Placing the sling correctly in the midurethra right
position rather than in the proximal urethra by an experienced
surgeon may avoid urinary retention and de novo urgency.
Unlike retropubic or transobturator slings, theMiniArc is a mini-
sling that requires tension, causing it to lie directly against the
urethra with no intervening space. In our prior study, involving
comparing the two inside-out procedures, the tension free TVT-O
resulted in a more signiﬁcant decrease in the maximal and
average ﬂow rates than the shorter tension sling MiniArc, even
though none of the patients experienced urinary retention imme-
diately or 1 year postoperation [7]. However, in the present
extended study, although none of the patients experienced urinary
retention immediately or over 1 year post-operation, we found a
statistically signiﬁcant decrease in the maximal ﬂow rate and
average ﬂow rate in the MUCP  40 cmH2O group, but not in the
MUCP < 40 cmH2O group at 3 months postoperation. These results
suggest that even the shorter tension SIS may result in a signiﬁcant
decrease in the postoperative maximal and average ﬂow rates but
that postoperative urinary retention rarely happens. The post-
operative MUCP decreased signiﬁcantly in the TVT-O group in our
prior study [7] as well as in another study [30]. In this study, there
was a statistically signiﬁcant decrease in the MUCP in the MUCP 
40 cmH2O group (p < 0.001), but a statistically signiﬁcant increase
in the MUCP < 40 cmH2O group (p ¼ 0.006). These ﬁndings may be
due to the greater tension being applied in those preoperative
lower MUCP patients. In addition, more importantly, this implies
another potential advantage of the MiniArc over conventional USI
surgery, due to the less invasive nature of the MiniArc. A pillow-
effect tape tension in the urethra with the less invasive nature of
SIS may explain this sustained or increased postoperative MUCP,
which may preserve urethral continence function and prevent
recurrent incontinence. It is possible that the signiﬁcant increase in
postoperative MUCP may contribute toward and play an important
role in the positive outcomes for the preoperative lowMUCP group
in this study. More cases and longer follow-ups are needed to
validate the clinical impacts of these important ﬁndings about
MUCP changes.
The present study was limited in that it was a nonedouble-
blinded retrospective study not involving a large number of par-
ticipants and the follow-up period was short. The patients with
MUCP < 40 cmH2O were statistically signiﬁcantly olderdthe mean
ages of the two group patients were all 50e60 yearsdwhich may
not risk factors affecting cure, although the statistical adjustmentwas not made for the potential confounder. Ethical approval does
not apply because this was a retrospective study aimed at
comparing clinical outcomes. This study suggests that more par-
ticipants and a longer follow-up period are needed for a more
speciﬁc evaluation.
Based on the objective and subjective measures observed in this
1-year study, SIS appears to be equally effective and safe for the
treatment of USI in patients with andwithout lowMUCP during the
over 1-year follow-up. Thus, this study shows encouraging results
for the use of the MiniArc sling as a ﬁrst-line treatment for female
patients with USI even with low pre-operational MUCP.
However, further randomized, controlled trials and long-term
results are still required to deﬁne the role of the new sling sys-
tem in comparison with the other established midurethral tape
techniques for treating female USI with low preoperational MUCP.Conﬂicts of interest
The authors declare that they have no conﬂict of interest any of
the authors.References
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